Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958747 · ClinicalTrials.gov registry record · NA
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03958747 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT03958747, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in participants with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer participants treated with the chemotherapy drug called oxaliplatin.
Interventions
- OTHER Blood draw
- PROCEDURE Skin Biopsy
- DIAGNOSTIC_TEST Ultrasound - Serial and Tibial Nerve
- OTHER Abbreviated Neurologic Exam
- DIAGNOSTIC_TEST Nerve Conduction Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2025-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03958747
The ClinicalTrials.gov registry entry for NCT03958747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT03958747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03958747 about?
NCT03958747 is a clinical study titled "Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy". This pilot clinical trial studies how well ultrasound works in detecting oxaliplatin-induced neuropathy in participants with gastrointestinal cancer. Ultrasound may work better in diagnosing and detecting neuropathy in gastrointestinal cancer participants treated with the chemotherapy drug called ox...
What is the current status of trial NCT03958747?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-12-17. Estimated completion is 2025-11-26.
What interventions are being tested in trial NCT03958747?
The interventions under investigation include: Blood draw (OTHER), Skin Biopsy (PROCEDURE), Ultrasound - Serial and Tibial Nerve (DIAGNOSTIC_TEST), Abbreviated Neurologic Exam (OTHER), Nerve Conduction Study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03958747?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.